Oruka Therapeutics, Inc. (ORKA)

NASDAQ

$80.45

$-1.72

(-2.09%)

Previous Close: ⁦$82.11⁩

Market Closed

Oruka Therapeutics, Inc. (ORKA) Live Price Chart

Last updated: ⁦2026-10-13 05:12:00⁩. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.

Summary

Oruka Therapeutics, Inc. (ORKA) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $80.45, with a market capitalisation of $5.44B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $24.46 to $115.52. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$5.44B
Open	$81.81
Day's High	$115.52
Day's Low	$5.49
Previous Close	$82.11
Volume	442.39K
Average Volume	909.86K
P/E Ratio	--
52-Week High	$115.52
52-Week Low	$24.46
Dividend Yield	--
Earnings Date	--

Oruka Therapeutics, Inc. (ORKA) Latest Closing Stock Price

Oruka Therapeutics, Inc. (ORKA) last closed at $82.11 as of 2026-10-12 23:31:00, unchanged from the previous close of $82.11.

During the latest regular trading session, ORKA traded between $5.49 and $115.52, with a volume of 442.39K shares. The closing price was near the upper end and near the middle of its 52-week range.

Oruka Therapeutics, Inc. (ORKA) 7-Day Stock Price Change

Over the past seven days, Oruka Therapeutics, Inc. (ORKA) moved from $83.42 to $80.45, representing a decline of 3.56% ($2.97).

The stock traded between $75.83 and $86.00 during the period. The latest price is near the middle of the 7-day range, indicating moderate downward.

The average daily volume was 928.04 thousand shares, down versus the previous seven-day period, indicating lower trading activity.

ORKA 52-Week Price Position

Position in Range: 61.5%

52W Low$24.46

52W High$115.52

ORKA is currently trading at $80.45, placing it 61.5% of the way from its 52-week low of $24.46 to its 52-week high of $115.52. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Oruka Therapeutics, Inc. (ORKA)?

Oruka Therapeutics Inc a clinical-stage biopharmaceutical company focused on developing novel monoclonal antibody therapeutics for psoriasis (PsO) and other inflammatory and immunology (I&I) indications. Its programs are to treat and potentially modify disease by targeting mechanisms with efficacy and safety involved in disease pathology and the activity of pathogenic tissue-resident memory T cells (TRMs). Its program, ORKA-001, is designed to target the p19 subunit of interleukin-23 (IL-23p19) for the treatment of PsO. Its co-lead program, ORKA-002, is designed to target interleukin-17A and interleukin-17F (IL-17A/F) for the treatment of PsO, hidradenitis suppurativa (HS), psoriatic arthritis (PsA), and other conditions.

Oruka Therapeutics, Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	68
Exchange	NASDAQ
Company Website	https://www.orukatx.com

How to Buy Oruka Therapeutics, Inc. (ORKA) Stock on MEXC

Eligible investors can buy real shares of Oruka Therapeutics, Inc. (ORKA) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licenced broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for ORKA and Place Your Order

Open the RealStocks trading page and search for ORKA. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Oruka Therapeutics, Inc. (ORKA) stock price today?

Oruka Therapeutics, Inc. (ORKA) is currently trading at $ 80.45, down 2.02% ($1.66) from the previous close of $ 82.11. Intraday prices update in real time during regular trading hours.

2.Is ORKA stock going up or down today?

As of 2026-10-12 23:31:00, ORKA is trading at $ 80.45, down 2.02% ($1.66) from its previous close of $ 82.11. The stock has traded between $ 5.49 and $ 115.52 during today’s regular session. Past price movements do not guarantee future results.

3.What is ORKA pre-market price?

As of 2026-10-12 23:31:00, ORKA is trading at $ 81.99 in pre-market trading, down 0.15% ($0.12) from the previous close of $ 82.11. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is ORKA after-hours price?

As of 2026-10-12 23:31:00, ORKA is trading at $ 80.71 in after-hours trading, down 1.71% ($1.40) from the regular-session close of $ 82.11. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is ORKA stock trading now?

ORKA trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does ORKA sit relative to its 52-week high and low?

Over the past 52 weeks, ORKA has traded between a low of $ 24.46 and a high of $ 115.52. At $ 80.45, the stock is positioned 61.5% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Oruka Therapeutics, Inc. in?

Oruka Therapeutics, Inc. (ORKA) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Oruka Therapeutics, Inc.'s market capitalisation and where is it listed?

Oruka Therapeutics, Inc. is listed on the NASDAQ exchange with a market capitalisation of $ 5.44B. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is ORKA valued in terms of P/E ratio and EPS?

ORKA trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -1.74. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Oruka Therapeutics, Inc. pay a dividend?

Oruka Therapeutics, Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.